Chemo-hyperthermic peritoneal perfusion (CHPP) for appendiceal pseudomyxoma peritonei

[1] Dixit A.(2007)Appendiceal mucoceles and pseudomyxoma peritonei World J Gastroenterol 13 2381-2384

[2] Robertson J.H.P.(2005)Long-term survival following treatment of pseudomyxoma peritonei. An analysis of surgical therapy Ann Surg 241 300-308

[3] Mudan S.S.(2001)Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome Eur J Surg Oncol 27 239-243

[4] Miner T.J.(2007)Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 104-109

[5] Shia J.(1995)Disseminated peritoneal adenomucinous and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei” Ann J Surg Pathol 19 1390-1408

[6] Jaques D.P.(1986)The effects of preventive or therapeutic continuous hyperthermic peritoneal perfusion Hyperthermic Oncology in Japan 86 277-278

[7] Sugarbaker P.H.(1988)Continuous hyperthermic peritoneal perfusion using peritoneal cavity expander Hyperthermic Oncology 1 450-451

[8] Smeenk R.M.(2005)Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy Tech Coloproctol 9 95-103

[9] Verwaal V.J.(1984)Thermal dose determination in cancer therapy Int J Radiat Oncol Biol Phys 10 787-800

[10] Antonini N.(2003)Surgery combined with peritonectomy procedures and intraperitoneal chemotherapy in abdominal cancers with peritoneal carcinomatosis; a phase II study J Clin Oncol 21 799-806

[1] Dixit A.(2007)Appendiceal mucoceles and pseudomyxoma peritonei World J Gastroenterol 13 2381-2384

[2] Robertson J.H.P.(2005)Long-term survival following treatment of pseudomyxoma peritonei. An analysis of surgical therapy Ann Surg 241 300-308

[3] Mudan S.S.(2001)Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome Eur J Surg Oncol 27 239-243

[4] Miner T.J.(2007)Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 104-109

[5] Shia J.(1995)Disseminated peritoneal adenomucinous and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei” Ann J Surg Pathol 19 1390-1408

[6] Jaques D.P.(1986)The effects of preventive or therapeutic continuous hyperthermic peritoneal perfusion Hyperthermic Oncology in Japan 86 277-278

[7] Sugarbaker P.H.(1988)Continuous hyperthermic peritoneal perfusion using peritoneal cavity expander Hyperthermic Oncology 1 450-451

[8] Smeenk R.M.(2005)Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy Tech Coloproctol 9 95-103

[9] Verwaal V.J.(1984)Thermal dose determination in cancer therapy Int J Radiat Oncol Biol Phys 10 787-800

[10] Antonini N.(2003)Surgery combined with peritonectomy procedures and intraperitoneal chemotherapy in abdominal cancers with peritoneal carcinomatosis; a phase II study J Clin Oncol 21 799-806